Onkologie. 2014:8(2):61-63

Fertilits preservation in adolescent women with newly diagnosed cancer

Martin Huser, Igor Crha, Jana Žáková, Pavel Ventruba
Gynekologicko-porodnická klinika LF MU a Fakultní nemocnice Brno

Effective treatment of cancer often causes patients irreversible damage of reproductive abilities. Modern markers ovarian reserves are

introduced. These clinical examinations can effectively help to evaluate the risk of irreversible damage of gonadal cells done by oncology

disease or its curative treatment. The paper describes current oncofertility techiques implemented to clinical practice – embryo and

oocyte banking, ovarian tissue cryopreservation including further possibility of its orthotopic autotransplantation and administration

of gonadoliberin analogues for ovarian protection. Attention is applied to pro and contras of previously described methods of ovarian

protection in the discussion. Brief practical outcomes and recommendations are given for consultation caretakers in adolescent female

cancer patients threatened with significant fertility loss.

Keywords: infertility, reproductive protection, GnRH anlogues, ovarian tissu cryopreservation, oocyte vitrification

Published: May 10, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Huser M, Crha I, Žáková J, Ventruba P. Fertilits preservation in adolescent women with newly diagnosed cancer. Onkologie. 2014;8(2):61-63.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Huser M, Crha I, Záková J, Ventruba P. Proces reprodukčního stárnutí ženy, jeho příčiny a možnosti ovlivnění v praxi. Ceská Gynekol. Ceská Lékarská Spolecnost J Ev Purkyne 2010; 75: 353-358.
    2. Huser M, Smardová L, Ventruba P, Mayer J. Vliv onkologické léčby na lidskou reprodukci. Klin. Onkol. Cas. Ceské Slov. Onkol. Spolecnosti 2010; 23: 165-170.
    3. Anderson RA, Weddell A, Spoudeas HA, Douglas C, Shalet SM, Levitt G, et al. Do doctors discuss fertility issues before they treat young patients with cancer? Hum. Reprod. Oxf. Engl. 2008; 23: 2246-2251. Go to original source... Go to PubMed...
    4. Woodruff TK. The Oncofertility Consortium-addressing fertility in young people with cancer. Nat. Rev. Clin. Oncol. 2010; 7: 466-475. Go to original source... Go to PubMed...
    5. Crha I, Ventruba P, Zakova J, Huser M, Kubesova B, Hudecek R, et al. Survival and infertility treatment in male cancer patients after sperm banking. Fertil. Steril. 2009; 91: 2344-2348. Go to original source... Go to PubMed...
    6. Zakova J, Lousova E, Ventruba P, Crha I, Pochopova H, Vinklárková J, et al. Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility. Sci. J. 2014; vol. 2014: 1-9. Go to original source... Go to PubMed...
    7. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983; 305: 707-709. Go to original source... Go to PubMed...
    8. Ventruba P, Mardesic T, Pilka L, Crha I, Visnová H, Hudecek R. Národní registr asistované reprodukce: Výsledky a analýza komplikací. Ceská Gynekol. Ceská Lékarská Spolecnost J Ev Purkyne 1998; 63: 107-110.
    9. Fasano G, Fontenelle N, Vannin A-S, Biramane J, Devreker F, Englert Y, et al. A randomized controlled trial comparing two vitrification methods versus slow-freezing for cryopreservation of human cleavage stage embryos. J. Assist. Reprod. Genet. 2013. Go to original source... Go to PubMed...
    10. Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil. Steril. 2013; 99: 1496-1502. Go to original source... Go to PubMed...
    11. Liu KE, Greenblatt EM. Oocyte cryopreservation in Canada: a survey of Canadian ART clinics. J. Obstet. Gynaecol. Can. JOGC J. Obstétrique Gynécologie Can. JOGC 2012; 34: 250-256. Go to original source... Go to PubMed...
    12. Cil AP, Seli E. Current trends and progress in clinical applications of oocyte cryopreservation. Curr. Opin. Obstet. Gynecol. 2013; 25: 247-254. Go to original source... Go to PubMed...
    13. Huser M, Záková J, Crha I, Smardová L, Král Z, Revel A, et al. Kryokonzervace ovariální tkáně u onkologických pacientek - 6 let klinických zkušeností. Ceská Gynekol. Ceská Lékarská Spolecnost J Ev Purkyne 2012; 77: 118-126.
    14. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod. Biomed. Online 2005; 10: 729-734. Go to original source... Go to PubMed...
    15. Huser M, Crha I, Hudecek R, Ventruba P, Zakova J, Smardova L, et al. Ovarian tissue cryopreservation-new opportunity to preserve fertility in female cancer patients. Eur. J. Gynaecol. Oncol. 2007; 28: 249-255. Go to PubMed...
    16. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-1410. Go to original source... Go to PubMed...
    17. Herraiz S, Novella-Maestre E, Rodríguez B, Díaz C, Sánchez-Serrano M, Mirabet V, et al. Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices. Fertil. Steril. 2013. Go to original source...
    18. Andersen CY, Kristensen SG, Greve T, Schmidt KT. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. Lond. Engl. 2012; 8: 595-608. Go to original source... Go to PubMed...
    19. Kim SS, Kang HG, Kim NH, Lee HC, Lee HH. Assessment of the integrity of human oocytes retrieved from cryopreserved ovarian tissue after xenotransplantation. Hum. Reprod. Oxf. Engl. 2005; 20: 2502-2508. Go to original source... Go to PubMed...
    20. Jin X, Xiao L-J, Zhang X-S, Liu Y-X. Apotosis in ovary. Front. Biosci. Sch. Ed. 2011; 3: 680-697. Go to original source...
    21. Metallinou C, Asimakopoulos B, Schröer A, Nikolettos N. Gonadotropin-releasing hormone in the ovary. Reprod. Sci. Thousand Oaks Calif 2007; 14: 737-749. Go to original source... Go to PubMed...
    22. Ataya K, Rao LV, Lawrence E, Kimmel R. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol. Reprod. 1995; 52: 365-372. Go to original source... Go to PubMed...
    23. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA J. Am. Med. Assoc. 2011; 306: 269-276. Go to original source... Go to PubMed...
    24. Demeestere I, Brice P, Peccatori FA, Kentos A, Gaillard I, Zachee P, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2013; 31: 903-909. Go to original source... Go to PubMed...
    25. Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil. Steril. 2011; 95: 906-914. e1-4. Go to original source... Go to PubMed...
    26. Huser M, Crha I, Ventruba P, Hudecek R, Zakova J, Smardova L, et al. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum. Reprod. Oxf. Engl. 2008; 23: 863-868. Go to original source... Go to PubMed...
    27. Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst. Rev. 2011; CD008018. Go to original source...
    28. Huser M, Zakova J, Smardova L, Crha I, Janku P, Hudecek R, et al. Combination of fertility preservation strategies in young women with recently diagnosed cancer. Eur. J. Gynaecol. Oncol. 2012; 33: 42-50. Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.